Tackling a Life-Long Respiratory Battle Affecting Nearly One-Third of Survivors

  Bronchopulmonary dysplasia (BPD) remains a significant respiratory complication in extremely preterm infants, with up to 30% mortality in those born before 32 weeks. A systematic review of five key studies reveals varied efficacy of treatments: extended dexamethasone regimens improve survival and reduce ventilation duration; early erythropoietin lowers BPD incidence; whereas corticosteroids and diuretics show limited benefits. BPD is also associated with serious airway complications, emphasizing the need for multidisciplinary, evidence-based management. To explore comprehensive treatment insights and advances in managing BPD in neonatal care...

click here   ##Reference## Almutairi M, Alomari S, Alomari N, et al. Upper Airway Manifestations and Otolaryngologic Management of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review. ENT Updates. 2025;15(3):1-14.## In your…